TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $21,000 | -19.2% | 410 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $26,000 | -13.3% | 410 | 0.0% | 0.00% | -40.0% |
Q2 2021 | $30,000 | 0.0% | 410 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $30,000 | 0.0% | 410 | 0.0% | 0.01% | -16.7% |
Q4 2020 | $30,000 | +36.4% | 410 | 0.0% | 0.01% | +20.0% |
Q3 2020 | $22,000 | -18.5% | 410 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $27,000 | +8.0% | 410 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $25,000 | -30.6% | 410 | 0.0% | 0.01% | -25.0% |
Q4 2019 | $36,000 | +16.1% | 410 | 0.0% | 0.01% | +14.3% |
Q3 2019 | $31,000 | -11.4% | 410 | 0.0% | 0.01% | -12.5% |
Q2 2019 | $35,000 | -20.5% | 410 | 0.0% | 0.01% | -20.0% |
Q1 2019 | $44,000 | +780.0% | 410 | +831.8% | 0.01% | +400.0% |
Q4 2017 | $5,000 | 0.0% | 44 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $5,000 | 0.0% | 44 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $5,000 | – | 44 | +1000.0% | 0.00% | – |
Q1 2017 | $0 | -100.0% | 4 | -86.7% | 0.00% | -100.0% |
Q4 2016 | $3,000 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |